4SC to present at two upcoming investor conferences

BioCapital Europe Conference (17 April 2013, Amsterdam) / Kempen & Co. Healthcare & Life Sciences Conference (23 April 2013, Amsterdam)

(PresseBox) ( Planegg-Martinsried, )
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer and autoimmune diseases, will be presenting at two upcoming investor conferences.

Enno Spillner, Chief Executive Officer & Chief Financial Officer of 4SC AG, will give a company presentation at the BioCapital Europe conference, which will be held on 17 April 2013 in Amsterdam/The Netherlands. The presentation of 4SC will begin at 3.20pm (CEST).

Enno Spillner will also present 4SC to investors at the Kempen & Co. Healthcare & Life Sciences Conference, which will be held on 23 April 2013 in Amsterdam.

Legal Note

This document may contain projections or estimates relating to plans and objectives relating to our future operations, products, or services; future financial results; or assumptions underlying or relating to any such statements; each of which constitutes a forward-looking statement subject to risks and uncertainties, many of which are beyond our control. Actual results could differ materially, depending on a number of factors.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.